U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Duncan Jason (0001741553)
Mailing Address
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON MA 02109
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Neumora Therapeutics, Inc. 0001885522 2025-02-13 officer: See Remarks
ALBIREO PHARMA, INC. 0001322505 2018-06-04 officer: General Counsel


Items 1 - 65

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2025-02-13   Neumora Therapeutics, Inc. 4 A-Award --D 400000.0000 400000.0000 3 0001885522 Stock Option (Right to Buy)
D 2025-02-13   Neumora Therapeutics, Inc. 4 D-Return --D 400000.0000 0.0000 2 0001885522 Stock Option (Right to Buy)
A 2025-02-13   Neumora Therapeutics, Inc. 4 A-Award --D 500000.0000 500000.0000 1 0001885522 Stock Option (Right to Buy)
A 2023-12-11   Neumora Therapeutics, Inc. 4 A-Award --D 400000.0000 400000.0000 1 0001885522 Stock Option (Right to Buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 24337.0000 0.0000 4 0001322505 Stock Option (right to buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 U-Tender --D 3296.0000 0.0000 1 0001322505 Common Stock
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 15900.0000 0.0000 2 0001322505 Stock Option (right to buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 10063.0000 0.0000 3 0001322505 Stock Option (right to buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 23700.0000 0.0000 5 0001322505 Stock Option (right to buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 37500.0000 0.0000 6 0001322505 Stock Option (right to buy)
D 2023-03-02   ALBIREO PHARMA, INC. 4 D-Return --D 65850.0000 0.0000 7 0001322505 Restricted Stock Units
D 2023-01-23   ALBIREO PHARMA, INC. 4 S-Sale --D 228.0000 14146.0000 1 0001322505 Common Stock
A 2023-01-19   ALBIREO PHARMA, INC. 4/A A-Award --D 55000.0000 69146.0000 1 0001322505 Common Stock
A 2023-01-19   ALBIREO PHARMA, INC. 4 A-Award --D 55000.0000 69146.0000 1 0001322505 Common Stock
D 2023-01-19   ALBIREO PHARMA, INC. 4 S-Sale --D 938.0000 14374.0000 1 0001322505 Common Stock
D 2022-10-24   ALBIREO PHARMA, INC. 4 S-Sale --D 456.0000 14931.0000 3 0001322505 Common Stock
D 2022-10-24   ALBIREO PHARMA, INC. 4 S-Sale --D 104.0000 15483.0000 1 0001322505 Common Stock
D 2022-10-24   ALBIREO PHARMA, INC. 4 S-Sale --D 96.0000 15387.0000 2 0001322505 Common Stock
D 2022-07-25   ALBIREO PHARMA, INC. 4 S-Sale --D 220.0000 15587.0000 4 0001322505 Common Stock
D 2022-07-25   ALBIREO PHARMA, INC. 4 S-Sale --D 93.0000 15807.0000 3 0001322505 Common Stock
D 2022-07-22   ALBIREO PHARMA, INC. 4 S-Sale --D 238.0000 15900.0000 2 0001322505 Common Stock
D 2022-07-22   ALBIREO PHARMA, INC. 4 S-Sale --D 106.0000 16138.0000 1 0001322505 Common Stock
D 2022-04-25   ALBIREO PHARMA, INC. 4 S-Sale --D 91.0000 16008.0000 4 0001322505 Common Stock
D 2022-04-25   ALBIREO PHARMA, INC. 4 S-Sale --D 221.0000 16099.0000 3 0001322505 Common Stock
D 2022-04-22   ALBIREO PHARMA, INC. 4 S-Sale --D 103.0000 16320.0000 2 0001322505 Common Stock
D 2022-04-22   ALBIREO PHARMA, INC. 4 S-Sale --D 240.0000 16423.0000 1 0001322505 Common Stock
D 2022-01-24   ALBIREO PHARMA, INC. 4 S-Sale --D 1176.0000 16663.0000 3 0001322505 Common Stock
D 2022-01-24   ALBIREO PHARMA, INC. 4 S-Sale --D 96.0000 17839.0000 2 0001322505 Common Stock
D 2022-01-24   ALBIREO PHARMA, INC. 4 S-Sale --D 416.0000 17935.0000 1 0001322505 Common Stock
A 2022-01-18   ALBIREO PHARMA, INC. 4 A-Award --D 15900.0000 15900.0000 2 0001322505 Stock Option (right to buy)
A 2022-01-18   ALBIREO PHARMA, INC. 4 A-Award --D 10800.0000 18351.0000 1 0001322505 Common Stock
D 2021-10-25   ALBIREO PHARMA, INC. 4 S-Sale --D 217.0000 7355.0000 2 0001322505 Common Stock
D 2021-10-22   ALBIREO PHARMA, INC. 4 S-Sale --D 95.0000 7572.0000 1 0001322505 Common Stock
D 2021-07-23   ALBIREO PHARMA, INC. 4 S-Sale --D 223.0000 7667.0000 2 0001322505 Common Stock
D 2021-07-22   ALBIREO PHARMA, INC. 4 S-Sale --D 90.0000 7890.0000 1 0001322505 Common Stock
D 2021-06-25   ALBIREO PHARMA, INC. 4 M-Exempt --D 6300.0000 24337.0000 8 0001322505 Stock Option (right to buy)
D 2021-06-25   ALBIREO PHARMA, INC. 4 S-Sale --D 6300.0000 7980.0000 5 0001322505 Common Stock
A 2021-06-25   ALBIREO PHARMA, INC. 4 M-Exempt --D 6300.0000 14280.0000 4 0001322505 Common Stock
D 2021-06-24   ALBIREO PHARMA, INC. 4 M-Exempt --D 863.0000 30637.0000 7 0001322505 Stock Option (right to buy)
D 2021-06-24   ALBIREO PHARMA, INC. 4 M-Exempt --D 9137.0000 10063.0000 6 0001322505 Stock Option (right to buy)
D 2021-06-24   ALBIREO PHARMA, INC. 4 S-Sale --D 10000.0000 7980.0000 3 0001322505 Common Stock
A 2021-06-24   ALBIREO PHARMA, INC. 4 M-Exempt --D 863.0000 17980.0000 2 0001322505 Common Stock
A 2021-06-24   ALBIREO PHARMA, INC. 4 M-Exempt --D 9137.0000 17117.0000 1 0001322505 Common Stock
D 2021-04-23   ALBIREO PHARMA, INC. 4 S-Sale --D 222.0000 7849.0000 2 0001322505 Common Stock
D 2021-04-22   ALBIREO PHARMA, INC. 4 S-Sale --D 90.0000 8071.0000 1 0001322505 Common Stock
A 2021-04-01   ALBIREO PHARMA, INC. 4 M-Exempt --D 300.0000 8461.0000 2 0001322505 Common Stock
D 2021-04-01   ALBIREO PHARMA, INC. 4 S-Sale --D 300.0000 8161.0000 3 0001322505 Common Stock
D 2021-04-01   ALBIREO PHARMA, INC. 4 M-Exempt --D 300.0000 19200.0000 4 0001322505 Stock Option (right to buy)
D 2021-03-31   ALBIREO PHARMA, INC. 4 S-Sale --D 1426.0000 8161.0000 1 0001322505 Common Stock
D 2021-01-22   ALBIREO PHARMA, INC. 4 S-Sale --D 110.0000 9332.0000 2 0001322505 Common Stock
A 2021-01-21   ALBIREO PHARMA, INC. 4 A-Award --D 23700.0000 23700.0000 3 0001322505 Stock Option (right to buy)
A 2021-01-21   ALBIREO PHARMA, INC. 4 A-Award --D 5500.0000 9442.0000 1 0001322505 Common Stock
D 2020-10-22   ALBIREO PHARMA, INC. 4 S-Sale --D 89.0000 3781.0000 1 0001322505 Common Stock
D 2020-09-08   ALBIREO PHARMA, INC. 4 M-Exempt --D 3500.0000 19500.0000 3 0001322505 Stock Option (right to buy)
D 2020-09-08   ALBIREO PHARMA, INC. 4 S-Sale --D 4000.0000 3870.0000 2 0001322505 Common Stock
A 2020-09-08   ALBIREO PHARMA, INC. 4 M-Exempt --D 3500.0000 7870.0000 1 0001322505 Common Stock
D 2020-07-22   ALBIREO PHARMA, INC. 4 S-Sale --D 91.0000 4370.0000 1 0001322505 Common Stock
D 2020-04-22   ALBIREO PHARMA, INC. 4 S-Sale --D 92.0000 4461.0000 1 0001322505 Common Stock
D 2020-01-22   ALBIREO PHARMA, INC. 4 S-Sale --D 447.0000 4553.0000 1 0001322505 Common Stock
A 2020-01-21   ALBIREO PHARMA, INC. 4 A-Award --D 31500.0000 31500.0000 2 0001322505 Stock Option (right to buy)
A 2019-01-22   ALBIREO PHARMA, INC. 4 A-Award --D 5000.0000 5000.0000 1 0001322505 Common Stock
A 2019-01-22   ALBIREO PHARMA, INC. 4 A-Award --D 23000.0000 23000.0000 2 0001322505 Stock Option (right to buy)
A 2018-06-08   ALBIREO PHARMA, INC. 4 A-Award --D 37500.0000 37500.0000 1 0001322505 Stock Option (right to buy)
- -   Neumora Therapeutics, Inc. 3 - --- 1 - -
- -   ALBIREO PHARMA, INC. 3 - --- 1 - -

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016